[
    [
        {
            "time": "2023-10-01",
            "original_text": "Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "outpaces",
                    "stock market gains"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Lilly's Olumiant Meets Primary Endpoint in Coronavirus Study",
            "features": {
                "keywords": [
                    "Olumiant",
                    "meets",
                    "primary endpoint",
                    "coronavirus study"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Lilly's Olumiant Meets Primary Endpoint in Coronavirus Study",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Lilly Launches Digital Health Open Innovation Challenge to Help Transform Atopic Dermatitis Care",
            "features": {
                "keywords": [
                    "Lilly",
                    "launches",
                    "digital health",
                    "open innovation challenge",
                    "atopic dermatitis care"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Lilly Launches Digital Health Open Innovation Challenge to Help Transform Atopic Dermatitis Care",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Steve Cohen Finally Buys the Mets. You Can Buy the Braves.",
            "features": {
                "keywords": [
                    "Steve Cohen",
                    "buys",
                    "Mets",
                    "Braves"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "sports",
                    "investing"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Steve Cohen Finally Buys the Mets. You Can Buy the Braves.",
                "Correlation": 1,
                "Sentiment": 5,
                "Importance": 2,
                "Impact": 1,
                "Duration": 1,
                "Entity_Density": 1,
                "Market_Scope": 1,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "US FDA grants Fast Track designation to Jardiance® (empagliflozin) to improve outcomes following a heart attack",
            "features": {
                "keywords": [
                    "US FDA",
                    "Fast Track",
                    "Jardiance",
                    "empagliflozin",
                    "heart attack"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "US FDA grants Fast Track designation to Jardiance® (empagliflozin) to improve outcomes following a heart attack",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]